Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan.

Fabiani ME, Dinh DT, Nassis L, Casley DJ, Johnston CI.

Am J Hypertens. 2000 Sep;13(9):1005-13.

PMID:
10981551
2.

Pharmacologic properties of candesartan cilexetil--possible mechanisms of long-acting antihypertensive action.

Inada Y, Ojima M, Kanagawa R, Misumi Y, Nishikawa K, Naka T.

J Hum Hypertens. 1999 Jan;13 Suppl 1:S75-80. Review.

PMID:
10076925
3.
4.

Newly emerging pharmacologic differences in angiotensin II receptor blockers.

Oparil S.

Am J Hypertens. 2000 Jan;13(1 Pt 2):18S-24S. Review.

PMID:
10678284
5.
6.

Candesartan cilexetil: an angiotensin II receptor blocker.

Stoukides CA, McVoy HJ, Kaul AF.

Ann Pharmacother. 1999 Dec;33(12):1287-98. Review.

PMID:
10630830
7.

Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.

Israili ZH.

J Hum Hypertens. 2000 Apr;14 Suppl 1:S73-86. Review.

PMID:
10854085
8.

[Pharmacological profiles of candesartan cilexetil (TCV-116)].

Inada Y.

Nihon Rinsho. 1999 May;57(5):1130-6. Review. Japanese.

PMID:
10361446
9.

Improving antihypertensive efficacy while maintaining placebo-like tolerability.

Sever PS.

Blood Press Suppl. 2000;1:19-22. Review.

PMID:
11059631
10.

Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage.

Nishikawa K.

J Hum Hypertens. 1998 May;12(5):301-9. Review.

PMID:
9655651
11.

Putting the efficacy of candesartan cilexetil into perspective: a review of new comparative data.

Mallion JM, Badguet JP.

J Hum Hypertens. 2000 Oct;14 Suppl 2:S33-41. Review.

PMID:
11086634
13.

Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil.

Sever PS.

J Hypertens Suppl. 1997 Dec;15(6):S9-12. Review.

PMID:
9493121
14.

Candesartan cilexetil: an update of its use in essential hypertension.

Easthope SE, Jarvis B.

Drugs. 2002;62(8):1253-87. Review.

PMID:
12010090
15.
16.

Candesartan cilexetil: a new, long-acting, effective angiotensin II type 1 receptor blocker.

Sever P.

J Hum Hypertens. 1997 Sep;11 Suppl 2:S91-5. Review.

PMID:
9331018
17.

Differential clinical profile of candesartan compared to other angiotensin receptor blockers.

Cernes R, Mashavi M, Zimlichman R.

Vasc Health Risk Manag. 2011;7:749-59. doi: 10.2147/VHRM.S22591. Epub 2011 Dec 12. Review.

18.

Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.

Schmidt B, Schieffer B.

J Med Chem. 2003 Jun 5;46(12):2261-70. Review. No abstract available.

PMID:
12773029
20.

Cerebroprotective effects of angiotensin II (AT 1) receptor antagonists?

Drenthen W, Voors AA, Kappelle JL, van Veldhuisen DJ.

Neth Heart J. 2005 Apr;13(4):142-146. Review.

Supplemental Content

Support Center